株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管モニタリングおよび診断装置市場:製品(ECGシステム、イベントモニター、ホルターモニター、植め込み型ループレコーダー、ECG管理システム) - 産業分析、市場規模、シェア、成長、動向、予測 2017年〜2024年

Cardiovascular Monitoring and Diagnostic Devices Market (Product - ECG Systems, Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

発行 Transparency Market Research 商品コード 305310
出版日 ページ情報 英文 93 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.69円で換算しております。
Back to Top
心血管モニタリングおよび診断装置市場:製品(ECGシステム、イベントモニター、ホルターモニター、植め込み型ループレコーダー、ECG管理システム) - 産業分析、市場規模、シェア、成長、動向、予測 2017年〜2024年 Cardiovascular Monitoring and Diagnostic Devices Market (Product - ECG Systems, Event Monitors, Holter Monitors, Implantable Loop Recorders, ECG Management Systems) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
出版日: 2018年03月26日 ページ情報: 英文 93 Pages
概要

慢性疾患の広がりと高齢者の増加は、心血管モニタリングおよび診断装置市場を推進しています。政府機関、研究機関、および医療機関は、さまざまな心血管疾患の治療に注力しており、心血管モニタリング・診断装置に対する関心と投資の増加は、治療の発展を促進しています。糖尿病や肥満、心筋衰弱、高血圧に関連する健康リスクの増加なども当市場を促進する要因です。また、技術進歩により、埋め込み型診断装置が登場し、市場の成長にさらなる利益をもたらしています。

当レポートでは、世界の心血管モニタリングおよび診断装置市場について調査し、市場の概要、製品・地域別の市場動向、収益額の推移と予測、市場シェア、市場成長・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • レポートの説明
  • 市場セグメンテーション
  • 調査方法

第2章 エグゼクティブサマリー

  • 地域別の市場シェア(過去5年・今後7年間分)
  • 製品タイプ別の市場規模(過去5年・今後7年間分)
  • 市場のスナップショット

第3章 産業分析:世界の心血管モニタリングおよび診断装置市場

  • 産業概要
  • 市場の成長要因
  • 市場の阻害要因
  • 市場機会
  • ファイブフォース分析
  • 市場の魅力
  • 主要企業のマーケットポジション
  • 推奨事項
  • 世界の心血管モニタリング・診断装置市場:製品タイプ別の収益額
    • イントロダクション
    • 心電図システム
    • イベントモニター
    • ホルターモニター
    • 埋め込み型ループレコーダー
    • 心電図管理システム

第4章 世界の心血管モニタリング・診断装置市場:地域別の市場シェア

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第5章 企業プロファイル

  • Boston Scientific Corporation
  • フクダ電子
  • GE Healthcare
  • Hill-Rom Holdings, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • Medtronic plc
  • 日本光電
  • Philips Healthcare
  • Siemens Healthcare
  • Spacelabs Healthcare
  • St. Jude Medical, Inc.
目次

Cardiovascular Monitoring and Diagnostic Devices Market: Overview

The rising prevalence of chronic disease and the increasing geriatric population are propelling the global market for cardiovascular monitoring and diagnostic devices. Government, research, and healthcare bodies are focusing on the treatment of various cardiovascular diseases. The increased interest and investments from these bodies are fueling the development in the treatments of these generic diseases. The increasing number of people suffering from diabetes and obesity, heart muscle weakening, and increasing risks related to hypertension are other factors driving the market. Technological advancements have provided the devices with portability in conducting tests, which is further adding benefits to the market growth.

The overall market for cardiovascular monitoring and diagnostic devices is witnessing considerable expansion across various product segments such as ECG Systems, Event Monitors, Holter Monitors, Implantable Loop Recorders, and ECG Management Systems. Of these, the ECG Systems segments is expected to dominate the overall market over the forthcoming years.

The report on the cardiovascular monitoring and diagnostic devices market offers a detailed assessment of key factors influencing the market, such as opportunities, challenges, trends, restraints, and drivers. The research report also provides company profiles of prominent market players operating in the market.

Cardiovascular Monitoring and Diagnostic Devices Market: Trends and Opportunities

The rising number of deaths due to cardiovascular diseases is the key factor driving the market for cardiovascular monitoring and diagnostic devices. Various companies are utilizing the latest technologies and innovating products to improve their efficiency and effectively. Numerous medical institutes are initiating research and development programs, which could help the market transform over the forthcoming years. Furthermore, governments and not-profit organizations are starting awareness increasing programs, which is further anticipated to increase the adoption of highly advanced equipment among consumers.

It is expected that the rise in the geriatric population across the world will fuel the prevalence of cardiovascular diseases. The market is further anticipated to grow exponentially due to low cost of procedure and availability of reliable and affordable labor in the countries such as Turkey, India, China, and Indonesia. The growing consumptions of tobacco and alcohol, lack of physical activities, unhealthy food habits, and high level of stress are other factors leading to the risks of cardiovascular diseases. These factors ensure the healthy growth of the market for cardiovascular monitoring and diagnostic devices.

Cardiovascular Monitoring and Diagnostic Devices Market: Geographical Analysis

Geographically, the global cardiovascular monitoring and diagnostic devices market can be segmented into Latin America, Asia Pacific, Europe, North America, and rest of the world. Among these, the North America market is anticipated to lead the global market due to factors such as advanced healthcare infrastructure, rising awareness among consumers pertaining the availability of treatment and diagnosis methods, and the favorable policies initiated by the governments in the region. The Europe segment is following North America and is close to North America in terms of revenue owing to high incidence of cardiovascular diseases within the region. The Middle East and Asia Pacific are most likely to present potential opportunities for the market to grow due to developing healthcare infrastructure and adoption of various varieties of cardiovascular monitoring and diagnostic devices.

Cardiovascular Monitoring and Diagnostic Devices Market: Company mentioned

The market study presents profiling of prominent players operating in the global cardiovascular monitoring and diagnostic devices market. Key players in this market include GE Healthcare, Philips Healthcare, Spacelabs Healthcare, St. Jude Medical Inc., and Siemens Healthcare.

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product

  • ECG Systems
    • Resting ECG
    • Stress ECG
    • Event Monitors
    • Holter Monitors
    • Implantable Loop Recorders
  • ECG Management Systems

Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Rest of the World

This report gives access to decisive data, such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report include:

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography, 2013-2024 (US$ Mn)
  • 2.2. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Product Type, 2015 (US$ Mn)
  • 2.3. Global Cardiovascular Monitoring and Diagnosis Devices Market, by Geography, 2015 and 2024 (Value %)
  • 2.4. Cardiovascular Monitoring and Diagnosis Devices: Market Snapshot

3. Industry Analysis: Cardiovascular Monitoring and Diagnosis Devices Market

  • 3.1. Industry Overview
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Market Opportunities
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness
  • 3.7. Market Positioning of Key Players, (Value %) (2015)
  • 3.8. Recommendations
  • 3.9. Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Product Type, 2013-2024 (US$ Mn)
    • 3.9.1. Introduction
    • 3.9.2. ECG Systems
      • 3.9.2.1. Resting ECG Systems
      • 3.9.2.2. Stress ECG Systems
    • 3.9.3. Event Monitors
    • 3.9.4. Holter Monitors
    • 3.9.5. Implantable Loop Recorders
    • 3.9.6. ECG Management Systems

4. Global Cardiovascular Monitoring and Diagnosis Devices Market Share, by Geography

  • 4.1. Introduction: Global Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)
  • 4.2. North America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)
  • 4.3. Europe Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)
  • 4.4. Asia Pacific Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)
  • 4.5. Latin America Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)
  • 4.6. Rest of World Cardiovascular Monitoring and Diagnosis Devices Market Revenue, by Country and Product Type, 2013-2024 (US$ Mn)

5. Company Profiles

  • 5.1. Boston Scientific Corporation
    • 5.1.1. Company Overview
    • 5.1.2. Product Portfolio
    • 5.1.3. Financial Overview
    • 5.1.4. Product Portfolio
    • 5.1.5. Recent Developments
  • 5.2. Fukuda Denshi Co. Ltd.
    • 5.2.1. Company Overview
    • 5.2.2. Product Portfolio
    • 5.2.3. Financial Overview
    • 5.2.4. Product Portfolio
    • 5.2.5. Recent Developments
  • 5.3. GE Healthcare
    • 5.3.1. Company Overview
    • 5.3.2. Product Portfolio
    • 5.3.3. Financial Overview
    • 5.3.4. Product Portfolio
    • 5.3.5. Recent Developments
  • 5.4. Hill-Rom Holdings, Inc.
    • 5.4.1. Company Overview
    • 5.4.2. Product Portfolio
    • 5.4.3. Financial Overview
    • 5.4.4. Product Portfolio
    • 5.4.5. Recent Developments
  • 5.5. Johnson & Johnson
    • 5.5.1. Company Overview
    • 5.5.2. Product Portfolio
    • 5.5.3. Financial Overview
    • 5.5.4. Product Portfolio
    • 5.5.5. Recent Developments
  • 5.6. LivaNova PLC
    • 5.6.1. Company Overview
    • 5.6.2. Product Portfolio
    • 5.6.3. Financial Overview
    • 5.6.4. Product Portfolio
    • 5.6.5. Recent Developments
  • 5.7. Medtronic plc
    • 5.7.1. Company Overview
    • 5.7.2. Product Portfolio
    • 5.7.3. Financial Overview
    • 5.7.4. Product Portfolio
    • 5.7.5. Recent Developments
  • 5.8. Nihon Kohden Corporation
    • 5.8.1. Company Overview
    • 5.8.2. Product Portfolio
    • 5.8.3. Financial Overview
    • 5.8.4. Product Portfolio
    • 5.8.5. Recent Developments
  • 5.9. Philips Healthcare
    • 5.9.1. Company Overview
    • 5.9.2. Product Portfolio
    • 5.9.3. Financial Overview
    • 5.9.4. Product Portfolio Company Overview
    • 5.9.5. Product Portfolio
    • 5.9.6. Financial Overview
    • 5.9.7. Product Portfolio
    • 5.9.8. Recent Developments
    • 5.9.9. Recent Developments
  • 5.10. Siemens Healthcare
    • 5.10.1. Company Overview
    • 5.10.2. Product Portfolio
    • 5.10.3. Financial Overview
    • 5.10.4. Product Portfolio
    • 5.10.5. Recent Developments
  • 5.11. Spacelabs Healthcare (OSI Systems, Inc.)
    • 5.11.1. Company Overview
    • 5.11.2. Product Portfolio
    • 5.11.3. Financial Overview
    • 5.11.4. Product Portfolio
    • 5.11.5. Recent Developments
  • 5.12. St. Jude Medical, Inc.,
    • 5.12.1. Company Overview
    • 5.12.2. Product Portfolio
    • 5.12.3. Financial Overview
    • 5.12.4. Product Portfolio
    • 5.12.5. Recent Developments

List of Tables

  • TABLE 1: Cardiovascular Monitoring and Diagnostic Devices Market Snapshot
  • TABLE 2: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, (US$ Mn), 2013-2024
  • TABLE 3: Global ECG Systems Market Revenue (US$ Mn), 2013-2024
  • TABLE 4: Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, (US$ Mn), 2013-2024
  • TABLE 5: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013-2024
  • TABLE 6: North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013-2024
  • TABLE 7: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013-2024
  • TABLE 8: Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013-2024
  • TABLE 9: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013-2024
  • TABLE 10: Asia Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013-2024
  • TABLE 11: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Country (US$ Mn), 2013-2024
  • TABLE 12: Latin America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013-2024
  • TABLE 13: Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type (US$ Mn), 2013-2024

List of Figures

  • FIG 1. Market Segmentation
  • FIG 2. Global Cardiovascular Monitoring and Diagnostic Devices Market, Estimates and Forecast, by Revenue, (US$ Mn), 2013-2024
  • FIG 3. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, (US$ Mn), 2015
  • FIG 4. Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography, (Value %), 2015 and 2024
  • FIG 5. St. Jude Medical HeartMate 3 (Left Ventricular Assist System)
  • FIG 6. Global Population, by Age group (%) 2000
  • FIG 7. Global Population, by Age group (%) 2050
  • FIG 8. Porter's Five Forces Analysis: Cardiovascular Monitoring and Diagnostic Devices Market
  • FIG 9. Market Attractiveness Analysis - Cardiovascular Monitoring and Diagnostic Devices Market
  • FIG 10. Market Share of Companies, Cardiovascular Monitoring and Diagnostic Devices (%) (2015)
  • FIG 11. Global Resting ECG Systems Market Revenue, (US$ Mn), 2013-2024
  • FIG 12. Global Stress ECG Systems Market Revenue, (US$ Mn), 2013-2024
  • FIG 13. Global Event Monitors Market Revenue, (US$ Mn), 2013-2024
  • FIG 14. Global Holter Monitors Market Revenue, (US$ Mn), 2013-2024
  • FIG 15. Global Implantable Loop Recorders Market Revenue, (US$ Mn), 2013-2024
  • FIG 16. Global ECG Management Systems Market Revenue, (US$ Mn), 2013-2024
  • FIG 17. Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, (US$ Mn), 2013-2024
  • FIG 18. Boston Scientific Corporation Financial Overview (US$ Mn), 2013-2015
  • FIG 19. Fukuda Denshi Co., Ltd. Financial Overview (US$ Mn), 2013-2015
  • FIG 20. GE Healthcare Financial Overview (US$ Mn), 2013-2015
  • FIG 21. Hill-Rom Holdings, Inc. Financial Overview (US$ Mn), 2013-2015
  • FIG 22. Johnson & Johnson Financial Overview (US$ Mn), 2013-2015
  • FIG 23. Medtronic plc Financial Overview (US$ Mn), 2013-2015
  • FIG 24. Nihon Kohden Corporation Financial Overview (US$ Mn), 2013-2015
  • FIG 25. Philips Healthcare Financial Overview: (US$ Mn), 2013-2015
  • FIG 26. Siemens Healthcare Financial Overview (US$ Mn), 2013-2015
  • FIG 27. Spacelabs Healthcare Financial Overview (US$ Mn), 2013-2015
  • FIG 28. St. Jude Medical, Inc. Financial Overview (US$ Mn), 2013-2015
Back to Top